EuroMedtech™, to be held at the Westin Hotel in Leipzig, Germany on June 1–2, is fast becoming the premier event for established and emerging medtech companies and start-ups throughout Europe to present their unique value proposition to attain strategic partners and/or capital from venture or institutional investors.

This year’s EuroMedtech features a high-powered presentation forum that includes a next generation presentation track, designed to help innovative start-ups, spin-offs and technology transfer departments gain the attention of established medtech companies, large corporations and investors.

According to Anna Chérouvrier Hansson of Invest in Skåne, one of the trade associations of Medicon Valley that straddles Denmark and southern Sweden, “EuroMedtech is an ideal event for many of our medtech companies to present at. We have a thriving entrepreneurial and innovative medtech sector. Companies such as CarpoNovum, CLS, MedInvent and Laccure have the technology to grow and become significant firms in the medtech industry. Forming the ‘right’ partnerships at this stage of development is key to fulfilling their longer term vision.”

In recognition of the value that presenting at EuroMedtech offers, Deutsche Börse is actively encouraging many of its listed medtech companies, such as Geratherm Medical, Eckert & Ziegler, and aap Implantate to participate in the event. Stefan Höfer, Issuer & Investor Markets, Deutsche Börse AG, said, “In today’s marketplace companies need to actively market their story to the players who have the ability to positively affect a firm’s outlook. By presenting at EuroMedtech our companies can achieve significant business outcomes, such as forming a strategic partnership with a large medical company or gaining the attention of leading institutional investors in Europe.”

Powered by partneringONE®, the industry’s most advanced partnering system, EuroMedtech facilitates one-to-one meetings between emerging innovator firms, large multi-disciplinary healthcare and biomedical companies, investment firms and service providers. Companies interesting in applying to present can do so online at www.ebdgroup.com/emt.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations, and include:

• BIO-Europe and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• BioPharm America™, the fastest growing partnering event in North America
• EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
• ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
• Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.

Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information visit www.ebdgroup.com.